Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

5b98a2bc1d.Kdk-HGW4r0gknX5dC8t4GcCUxkv5VkzZB_M7-pZfYA4.TZcNazD16iF700drOP0UW67XqiGMEgSYSMNLnbsPTXpdiXdvNM7tOHz0Rg~ed211de735099c52b7b81da5a12189d5
11:11am AstraZeneca PLC : Berenberg reiterates its Buy rating ZD
09-09 RBC Capital Markets Initiates AstraZeneca Coverage at Outperform MT
09-09 RBC Initiates AstraZeneca at Outperform With GBP145 Price Target MT
09-09 RBC prefers Astra to GSK; HSBC cuts Burberry AN
09-09 RBC Initiates AstraZeneca at Outperform as Near-term Overhangs Create 'Attractive' Entry Point MT
09-09 AstraZeneca PLC : Gets a Buy rating from RBC ZD
09-08 AstraZeneca PLC : Buy rating from JP Morgan ZD
09-08 AstraZeneca PLC : Receives a Sell rating from Deutsche Bank ZD
09-08 Jefferies raises Autotrader and Rightmove AN
09-08 AstraZeneca PLC : Barclays maintains a Buy rating ZD
09-07 BofA Upbeat on AstraZeneca's Camizestrant After US Approval Based on Serena-6 Trial Results MT
09-07 AstraZeneca PLC : Gets a Buy rating from JP Morgan ZD
09-07 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
09-04 AstraZeneca: Share price weakness of late, should be capitalised on Alphavalue
09-03 AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout MT
09-02 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
09-01 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
08-28 AstraZeneca PLC : Jefferies reaffirms its Buy rating ZD
08-25 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
08-24 JPMorgan raises Diploma, Barclays cuts Unite AN
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-20 Goldman likes Astra; JPMorgan lowers Trainline AN
08-20 AstraZeneca PLC : Goldman Sachs reaffirms its Buy rating ZD
08-19 AstraZeneca PLC : Deutsche Bank reiterates its Sell rating ZD
08-19 AstraZeneca PLC : UBS reiterates its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.02%
+3.71%
+10.32%
+7.48%
+11.26%
+34.37%
-0.65%
+7.36%
+8.07%
Average +10.99%
Weighted average by Cap. +11.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
157.80USD
Average target price
212.04USD
Spread / Average Target
+34.37%
High Price Target
271.18USD
Spread / Highest target
+71.85%
Low Price Target
151.95USD
Spread / Lowest Target
-3.71%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!